-
1
-
-
84940859321
-
Anthrax pathogenesis
-
Moayeri M, Leppla SH, Vrentas C, Pomerantsev A, Liu S. 2015. Anthrax pathogenesis. Annu Rev Microbiol 69:185-208. http://dx.doi.org/10.1146/annurev-micro-091014-104523.
-
(2015)
Annu Rev Microbiol
, vol.69
, pp. 185-208
-
-
Moayeri, M.1
Leppla, S.H.2
Vrentas, C.3
Pomerantsev, A.4
Liu, S.5
-
2
-
-
80052155168
-
Monoclonal antibody therapies against anthrax
-
Basel
-
Chen Z, Moayeri M, Purcell R. 2011. Monoclonal antibody therapies against anthrax. Toxins (Basel) 3:1004-1019. http://dx.doi.org/10.3390/toxins3081004.
-
(2011)
Toxins
, vol.3
, pp. 1004-1019
-
-
Chen, Z.1
Moayeri, M.2
Purcell, R.3
-
3
-
-
84878714164
-
Nanobodies and their potential applications
-
Lond
-
Hassanzadeh-Ghassabeh G, Devoogdt N, De Pauw P, Vincke C, Muyl-dermans S. 2013. Nanobodies and their potential applications. Nanomedicine (Lond) 8:1013-1026. http://dx.doi.org/10.2217/nnm.13.86.
-
(2013)
Nanomedicine
, vol.8
, pp. 1013-1026
-
-
Hassanzadeh-Ghassabeh, G.1
Devoogdt, N.2
De Pauw, P.3
Vincke, C.4
Muyl-Dermans, S.5
-
4
-
-
84878935042
-
Nanobodies: Natural single-domain antibodies
-
Muyldermans S. 2013. Nanobodies: Natural single-domain antibodies. Annu Rev Biochem 82:775-797. http://dx.doi.org/10.1146/annurev-biochem-063011-092449.
-
(2013)
Annu Rev Biochem
, vol.82
, pp. 775-797
-
-
Muyldermans, S.1
-
5
-
-
84905174041
-
Adenoviral targeting using genetically incorporated camelid single variable domains
-
Kaliberov SA, Kaliberova LN, Buggio M, Tremblay JM, Shoemaker CB, Curiel DT. 2014. Adenoviral targeting using genetically incorporated camelid single variable domains. Lab Invest 94:893-905. http://dx.doi.org/10.1038/labinvest.2014.82.
-
(2014)
Lab Invest
, vol.94
, pp. 893-905
-
-
Kaliberov, S.A.1
Kaliberova, L.N.2
Buggio, M.3
Tremblay, J.M.4
Shoemaker, C.B.5
Curiel, D.T.6
-
6
-
-
84924787113
-
A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model
-
Moayeri M, Leysath CE, Tremblay JM, Vrentas C, Crown D, Leppla SH, Shoemaker CB. 2015. A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model. J Biol Chem 290:6584-6595. http://dx.doi.org/10.1074/jbc.M114.627943.
-
(2015)
J Biol Chem
, vol.290
, pp. 6584-6595
-
-
Moayeri, M.1
Leysath, C.E.2
Tremblay, J.M.3
Vrentas, C.4
Crown, D.5
Leppla, S.H.6
Shoemaker, C.B.7
-
7
-
-
84919484445
-
Prolonged prophylactic protection from botulism with a single adenovirus treatment promoting serum expression of a VHH-based antitoxin protein
-
Mukherjee J, Dmitriev I, Debatis M, Tremblay JM, Beamer G, Kashentseva EA, Curiel DT, Shoemaker CB. 2014. Prolonged prophylactic protection from botulism with a single adenovirus treatment promoting serum expression of a VHH-based antitoxin protein. PLoS One 9:e106422. http://dx.doi.org/10.1371/journal.pone.0106422.
-
(2014)
PLoS One
, vol.9
, pp. e106422
-
-
Mukherjee, J.1
Dmitriev, I.2
Debatis, M.3
Tremblay, J.M.4
Beamer, G.5
Kashentseva, E.A.6
Curiel, D.T.7
Shoemaker, C.B.8
-
8
-
-
84855455375
-
A novel strategy for development of recombinant antitoxin therapeutics tested in a mouse botulism model
-
Mukherjee J, Tremblay JM, Leysath CE, Ofori K, Baldwin K, Feng X, Bedenice D, Webb RP, Wright PM, Smith LA, Tzipori S, Shoemaker CB. 2012. A novel strategy for development of recombinant antitoxin therapeutics tested in a mouse botulism model. PLoS One 7:e29941. http://dx.doi.org/10.1371/journal.pone.0029941.
-
(2012)
PLoS One
, vol.7
, pp. e29941
-
-
Mukherjee, J.1
Tremblay, J.M.2
Leysath, C.E.3
Ofori, K.4
Baldwin, K.5
Feng, X.6
Bedenice, D.7
Webb, R.P.8
Wright, P.M.9
Smith, L.A.10
Tzipori, S.11
Shoemaker, C.B.12
-
9
-
-
84919474729
-
Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication
-
Sheoran AS, Dmitriev IP, Kashentseva EA, Cohen O, Mukherjee J, Debatis M, Shearer J, Tremblay JM, Beamer G, Curiel DT, Shoemaker CB, Tzipori S. 2015. Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication. Infect Immun 83:286-291. http://dx.doi.org/10.1128/IAI.02360-14.
-
(2015)
Infect Immun
, vol.83
, pp. 286-291
-
-
Sheoran, A.S.1
Dmitriev, I.P.2
Kashentseva, E.A.3
Cohen, O.4
Mukherjee, J.5
Debatis, M.6
Shearer, J.7
Tremblay, J.M.8
Beamer, G.9
Curiel, D.T.10
Shoemaker, C.B.11
Tzipori, S.12
-
10
-
-
84890940453
-
A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2
-
Tremblay JM, Mukherjee J, Leysath CE, Debatis M, Ofori K, Baldwin K, Boucher C, Peters R, Beamer G, Sheoran A, Bedenice D, Tzipori S, Shoemaker CB. 2013. A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2 Infect Immun 81:4592-4603. http://dx.doi.org/10.1128/IAI.01033-13.
-
(2013)
Infect Immun
, vol.81
, pp. 4592-4603
-
-
Tremblay, J.M.1
Mukherjee, J.2
Leysath, C.E.3
Debatis, M.4
Ofori, K.5
Baldwin, K.6
Boucher, C.7
Peters, R.8
Beamer, G.9
Sheoran, A.10
Bedenice, D.11
Tzipori, S.12
Shoemaker, C.B.13
-
11
-
-
84907102875
-
A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice
-
Yang Z, Schmidt D, Liu W, Li S, Shi L, Sheng J, Chen K, Yu H, Tremblay JM, Chen X, Piepenbrink KH, Sundberg EJ, Kelly CP, Bai G, Shoemaker CB, Feng H. 2014. A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice. J Infect Dis 210:964-972. http://dx.doi.org/10.1093/infdis/jiu196.
-
(2014)
J Infect Dis
, vol.210
, pp. 964-972
-
-
Yang, Z.1
Schmidt, D.2
Liu, W.3
Li, S.4
Shi, L.5
Sheng, J.6
Chen, K.7
Yu, H.8
Tremblay, J.M.9
Chen, X.10
Piepenbrink, K.H.11
Sundberg, E.J.12
Kelly, C.P.13
Bai, G.14
Shoemaker, C.B.15
Feng, H.16
-
12
-
-
84890918372
-
Stepwise engineering of heterodimeric single domain camelidVHHantibodies that passively protect mice from ricin toxin
-
Vance DJ, Tremblay JM, Mantis NJ, Shoemaker CB. 2013. Stepwise engineering of heterodimeric single domain camelidVHHantibodies that passively protect mice from ricin toxin. J Biol Chem 288:36538-36547. http://dx.doi.org/10.1074/jbc.M113.519207.
-
(2013)
J Biol Chem
, vol.288
, pp. 36538-36547
-
-
Vance, D.J.1
Tremblay, J.M.2
Mantis, N.J.3
Shoemaker, C.B.4
-
13
-
-
37549040584
-
Rapid/sustained antianthrax passive immunity mediated by co-administration of Ad/AAV
-
De BP, Hackett NR, Crystal RG, Boyer JL. 2008. Rapid/sustained antianthrax passive immunity mediated by co-administration of Ad/AAV. Mol Ther 16:203-209. http://dx.doi.org/10.1038/sj.mt.6300344.
-
(2008)
Mol Ther
, vol.16
, pp. 203-209
-
-
De BP1
Hackett, N.R.2
Crystal, R.G.3
Boyer, J.L.4
-
14
-
-
63149166807
-
Adenovirus-mediated delivery of an anti-V antigen monoclonal antibody protects mice against a lethal Yersinia pestis challenge
-
Sofer-Podesta C, Ang J, Hackett NR, Senina S, Perlin D, Crystal RG, Boyer JL. 2009. Adenovirus-mediated delivery of an anti-V antigen monoclonal antibody protects mice against a lethal Yersinia pestis challenge. Infect Immun 77:1561-1568. http://dx.doi.org/10.1128/IAI.00856-08.
-
(2009)
Infect Immun
, vol.77
, pp. 1561-1568
-
-
Sofer-Podesta, C.1
Ang, J.2
Hackett, N.R.3
Senina, S.4
Perlin, D.5
Crystal, R.G.6
Boyer, J.L.7
-
15
-
-
84873050655
-
Passive immunization with a recombinant adenovirus expressing an HA (H5)-specific single-domain antibody protects mice from lethal influenza infection
-
Tutykhina IL, Sedova ES, Gribova IY, Ivanova TI, Vasilev LA, Rutovskaya Rutovskaya MV, Lysenko AA, Shmarov MM, Logunov DY, Naroditsky BS, Tillib SV, Gintsburg AL. 2013. Passive immunization with a recombinant adenovirus expressing an HA (H5)-specific single-domain antibody protects mice from lethal influenza infection. Antiviral Res 97:318-328. http://dx.doi.org/10.1016/j.antiviral.2012.12.021.
-
(2013)
Antiviral Res
, vol.97
, pp. 318-328
-
-
Tutykhina, I.L.1
Sedova, E.S.2
Gribova, I.Y.3
Ivanova, T.I.4
Vasilev, L.A.5
Rutovskaya Rutovskaya, M.V.6
Lysenko, A.A.7
Shmarov, M.M.8
Logunov, D.Y.9
Naroditsky, B.S.10
Tillib, S.V.11
Gintsburg, A.L.12
-
16
-
-
84936935341
-
Engineering humoral immunity as prophylaxis or therapy
-
Deal CE, Balazs AB. 2015. Engineering humoral immunity as prophylaxis or therapy. Curr Opin Immunol 35:113-122. http://dx.doi.org/10.1016/j.coi.2015.06.014.
-
(2015)
Curr Opin Immunol
, vol.35
, pp. 113-122
-
-
Deal, C.E.1
Balazs, A.B.2
-
17
-
-
84921327276
-
In situ production of therapeutic monoclonal antibodies
-
Suscovich TJ, Alter G. 2015. In situ production of therapeutic monoclonal antibodies. Expert Rev Vaccines 14:205-219. http://dx.doi.org/10.1586/14760584.2015.1001375.
-
(2015)
Expert Rev Vaccines
, vol.14
, pp. 205-219
-
-
Suscovich, T.J.1
Alter, G.2
-
18
-
-
0034049623
-
Optimized production and purification of Bacillus anthracis lethal factor
-
Park S, Leppla SH. 2000. Optimized production and purification of Bacillus anthracis lethal factor. Protein Expr Purif 18:293-302. http://dx.doi.org/10.1006/prep.2000.1208.
-
(2000)
Protein Expr Purif
, vol.18
, pp. 293-302
-
-
Park, S.1
Leppla, S.H.2
-
19
-
-
29644438843
-
Genome engineering in Bacillus anthracis using Cre recombinase
-
Pomerantsev AP, Sitaraman R, Galloway CR, Kivovich V, Leppla SH. 2006. Genome engineering in Bacillus anthracis using Cre recombinase. Infect Immun 74:682-693. http://dx.doi.org/10.1128/IAI.74.1.682-693.2006.
-
(2006)
Infect Immun
, vol.74
, pp. 682-693
-
-
Pomerantsev, A.P.1
Sitaraman, R.2
Galloway, C.R.3
Kivovich, V.4
Leppla, S.H.5
-
20
-
-
34250378403
-
A protocol for rapid generation of recombinant adenoviruses using the AdEasy system
-
Luo J, Deng ZL, Luo X, Tang N, Song WX, Chen J, Sharff KA, Luu HH, Haydon RC, Kinzler KW, Vogelstein B, He TC. 2007. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2:1236-1247. http://dx.doi.org/10.1038/nprot.2007.135.
-
(2007)
Nat Protoc
, vol.2
, pp. 1236-1247
-
-
Luo, J.1
Deng, Z.L.2
Luo, X.3
Tang, N.4
Song, W.X.5
Chen, J.6
Sharff, K.A.7
Luu, H.H.8
Haydon, R.C.9
Kinzler, K.W.10
Vogelstein, B.11
He, T.C.12
-
21
-
-
84946944111
-
Mechanisms of ricin toxin neutralization revealed through engineered homodimeric and heterodimeric camelid antibodies
-
Herrera C, Tremblay JM, Shoemaker CB, Mantis NJ. 2015. Mechanisms of ricin toxin neutralization revealed through engineered homodimeric and heterodimeric camelid antibodies. J Biol Chem 290:27880-27889. http://dx.doi.org/10.1074/jbc.M115.658070.
-
(2015)
J Biol Chem
, vol.290
, pp. 27880-27889
-
-
Herrera, C.1
Tremblay, J.M.2
Shoemaker, C.B.3
Mantis, N.J.4
-
22
-
-
78651258397
-
Inflammasome sensor Nlrp1bdependent resistance to anthrax is mediated by caspase-1, IL-1 signaling and neutrophil recruitment
-
Moayeri M, Crown D, Newman ZL, Okugawa S, Eckhaus M, Cataisson C, Liu S, Sastalla I, Leppla SH. 2010. Inflammasome sensor Nlrp1bdependent resistance to anthrax is mediated by caspase-1, IL-1 signaling and neutrophil recruitment. PLoS Pathog 6:e1001222. http://dx.doi.org/10.1371/journal.ppat.1001222.
-
(2010)
PLoS Pathog
, vol.6
, pp. e1001222
-
-
Moayeri, M.1
Crown, D.2
Newman, Z.L.3
Okugawa, S.4
Eckhaus, M.5
Cataisson, C.6
Liu, S.7
Sastalla, I.8
Leppla, S.H.9
-
23
-
-
0034254715
-
Soluble CD8 attenuates cytotoxic T cell responses against replication-defective adenovirus affording transprotection of transgenes in vivo
-
Peng Y, Falck-Pedersen E, Elkon KB. 2000. Soluble CD8 attenuates cytotoxic T cell responses against replication-defective adenovirus affording transprotection of transgenes in vivo. J Immunol 165:1470-1478. http://dx.doi.org/10.4049/jimmunol.165.3.1470.
-
(2000)
J Immunol
, vol.165
, pp. 1470-1478
-
-
Peng, Y.1
Falck-Pedersen, E.2
Elkon, K.B.3
-
24
-
-
0035027216
-
Variation in adenovirus transgene expression between BALB/c and C57BL/6 mice is associated with differences in interleukin-12 and gamma interferon production and NK cell activation
-
Peng Y, Falck-Pedersen E, Elkon KB. 2001. Variation in adenovirus transgene expression between BALB/c and C57BL/6 mice is associated with differences in interleukin-12 and gamma interferon production and NK cell activation. J Virol 75:4540-4550. http://dx.doi.org/10.1128/JVI.75.10.4540-4550.2001.
-
(2001)
J Virol
, vol.75
, pp. 4540-4550
-
-
Peng, Y.1
Falck-Pedersen, E.2
Elkon, K.B.3
-
25
-
-
84862102122
-
Derivation of a myeloid cell-binding adenovirus for gene therapy of inflammation
-
Alberti MO, Roth JC, Ismail M, Tsuruta Y, Abraham E, Pereboeva L, Gerson SL, Curiel DT. 2012. Derivation of a myeloid cell-binding adenovirus for gene therapy of inflammation. PLoS One 7:e37812. http://dx.doi.org/10.1371/journal.pone.0037812.
-
(2012)
PLoS One
, vol.7
, pp. e37812
-
-
Alberti, M.O.1
Roth, J.C.2
Ismail, M.3
Tsuruta, Y.4
Abraham, E.5
Pereboeva, L.6
Gerson, S.L.7
Curiel, D.T.8
-
26
-
-
79953300992
-
Implications of the innate immune response to adenovirus and adenoviral vectors
-
Gregory SM, Nazir SA, Metcalf JP. 2011. Implications of the innate immune response to adenovirus and adenoviral vectors. Future Virol 6:357-374. http://dx.doi.org/10.2217/fvl.11.6.
-
(2011)
Future Virol
, vol.6
, pp. 357-374
-
-
Gregory, S.M.1
Nazir, S.A.2
Metcalf, J.P.3
-
27
-
-
11144248909
-
The innate immune response to adenovirus vectors
-
Muruve DA. 2004. The innate immune response to adenovirus vectors. Hum Gene Ther 15:1157-1166. http://dx.doi.org/10.1089/hum.2004.15.1157.
-
(2004)
Hum Gene Ther
, vol.15
, pp. 1157-1166
-
-
Muruve, D.A.1
-
28
-
-
84880220595
-
A myeloid cell-binding adenovirus efficiently targets gene transfer to the lung and escapes liver tropism
-
Alberti MO, Deshane JS, Chaplin DD, Pereboeva L, Curiel DT, Roth JC. 2013. A myeloid cell-binding adenovirus efficiently targets gene transfer to the lung and escapes liver tropism. Gene Ther 20:733-741. http://dx.doi.org/10.1038/gt.2012.91.
-
(2013)
Gene Ther
, vol.20
, pp. 733-741
-
-
Alberti, M.O.1
Deshane, J.S.2
Chaplin, D.D.3
Pereboeva, L.4
Curiel, D.T.5
Roth, J.C.6
|